Limited coverage criteria – dutasteride

Last updated on March 5, 2025

 

Return to Special Authority drug list 

Generic name

dutasteride

Strength & form

0.5 mg capsule

Special Authority criteria

Approval period

Diagnosis of benign prostatic hyperplasia

PLUS

Treatment failure or intolerance to alpha-blocking agents

Indefinite

Practitioner exemptions

  • None

Special notes

  • None

Special Authority request form(s)